Clinical Differences and Non-Alcoholic Fatty Liver Disease-Related Factors of Lean and Non-Lean Patients with Metabolic Syndrome
Authors:
- Punyisa BoonchaiPBPunyisa Boonchai
- Chayanis KositamongkolCKChayanis Kositamongkol
- Suchanart JitrukthaiSJSuchanart Jitrukthai
- Sukumal PhothiratSPSukumal Phothirat
- Euarat MepramoonEMEuarat Mepramoon
- Pongpol NimitpunyaPNPongpol Nimitpunya
- Weerachai SrivanichakornWSWeerachai Srivanichakorn
- Thanet ChaisathapholTCThanet Chaisathaphol
- Chaiwat WashirasaksiriCWChaiwat Washirasaksiri
- Chonticha AuesomwangCAChonticha Auesomwang
- Tullaya SitasuwanTSTullaya Sitasuwan
- Rungsima TinmaneeRTRungsima Tinmanee
Open Access
- 26 April 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (9) , 2445
Abstract
This study investigated differences in the clinical data and prevalence of lean and non-lean patients with non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MetS). Data on patients with MetS who had results of ultrasonography or transient elastography were collected from a Thai university hospital database. Patients with exclusion criteria for NAFLD diagnosis were excluded. Patients’ clinical characteristic and the performances of three non-invasive scoring systems (fatty liver index [FLI], fibrosis-4 [FIB-4] index, and NAFLD fibrosis score [NFS]) were evaluated. The 743 subjects were classified into two groups: lean MetS (131 patients) and non-lean MetS (612 patients). The NAFLD prevalence in the non-lean group (62.6%) was higher than that in the lean group (31.3%). The age-adjusted odds ratio was 3.43. Advanced fibrosis was detected in 7.6% of lean patients and 10.8% of non-lean patients. FLI was not sensitive enough to detect NAFLD in the lean group at a high cutoff, but it performed acceptably at a low cutoff. FIB-4 performed better than NFS in determining advanced fibrosis. NAFLD was more common in non-lean than lean patients. Lean patients with MetS had a relatively higher risk of NAFLD than the general population. FLI and FIB-4 index performed acceptably in both groups.Keywords
Funding Information
- Mahidol University (R016421006)
This publication has 47 references indexed in Scilit:
- Non-alcoholic fatty liver disease: The diagnosis and managementWorld Journal of Hepatology, 2015
- Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisalJournal of Hepatology, 2013
- Nonalcoholic Fatty Liver Disease in Lean Individuals in the United StatesMedicine, 2012
- Nonalcoholic fatty liver disease: Definitions, risk factors, and workupClinical Liver Disease, 2012
- Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adultsAlimentary Pharmacology & Therapeutics, 2011
- Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysisHepatology, 2011
- A comprehensive definition for metabolic syndromeDisease Models & Mechanisms, 2009
- Non-invasive evaluation of liver fibrosis using transient elastographyJournal of Hepatology, 2008
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Can We Apply the National Cholesterol Education Program Adult Treatment Panel Definition of the Metabolic Syndrome to Asians?Diabetes Care, 2004